Pediatric Cancer
Conditions
Brief summary
This pilot study will be a prospective, single arm study to investigate the feasibility and acceptability of a brief, telehealth, cognitive compensatory training intervention for children with a history of pediatric cancer at the University of Michigan. Study aims to enroll 10 children with a history of treatment for pediatric cancer, along with their caregiver.
Interventions
OTHERCognitive Compensatory Training
The intervention will include 5 weekly sessions (60-90 minutes each) of cognitive compensatory training (CCT) delivered virtually by a pediatric neuropsychologist.
Sponsors
University of Michigan Rogel Cancer Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Patient between the ages of 8 and 18 * Patient has a history of pediatric cancer * Patient is at least 6 months posttreatment completion * Patient and caregiver are fluent in English, as intervention materials are only available in English at this time. * Patient demonstrates deficits in attention and/or executive functioning as evidenced by either (a) performance below one standard deviation on at least one cognitive measure of attention or executive functioning, such as on the Conners Continuous Performance Test (CPT-3), Trail making Test A & B, Children's Category Test (CCT), and Wisconsin Card Sorting Test (WCST) and/or (b) executive functioning and attention problems are identified during screening with the research assistant.
Exclusion criteria
* Patient has a history of treatment for a pediatric brain tumor * Patient has a history of traumatic brain injury or seizures * Patient has a history of a developmental disorder (i.e., autism, intellectual disability), behavioral disorder (i.e., oppositional defiant disorder, conduct disorder), or mood disorder (i.e., disruptive mood dysregulation disorder) that would negatively interfere with patient's participation in the intervention.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Determining satisfaction and perceived benefit from study intervention based off of change in results from the BRIEF-2 questionnaire from baseline to 6 weeks post trial entry | 6 weeks from trial entry | Completion of Study Questionnaire, BRIEF-2, at time of enrollment at after intervention completion. |
| Determining satisfaction and perceived benefit from study intervention based off of change in results from the Conners 3 questionnaire from baseline to 6 weeks post trial entry | 6 weeks from trial entry | Completion of Study Questionnaire, Conners 3, at time of enrollment at after intervention completion. |
| Determining satisfaction and perceived benefit from study intervention based off of change in results from the SMALSI-2 questionnaire from baseline to 6 weeks post trial entry | 6 weeks from trial entry | Completion of Study Questionnaire, SMALSI-2, at time of enrollment at after intervention completion. |
| Determining satisfaction and perceived benefit from study intervention based off of change in results from the SPSI-R questionnaire from baseline to 6 weeks post trial entry | 6 weeks from trial entry | Completion of Study Questionnaires, SPSI-R , at time of enrollment at after intervention completion. |
| Determining satisfaction and perceived benefit from study intervention based off of change in results from the PKEQ questionnaire from baseline to 6 weeks post trial entry | 6 weeks from trial entry | Completion of Study Questionnaires, PKEQ, at time of enrollment at after intervention completion. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Study completion | 6 weeks from trial entry | Possible factors contributing to study completion will be gathered from the History Questionnaire |
| Clinical outcomes based off of response to the PKEQ study questionnaire | 6 weeks from trial entry | Clinical outcomes of the intervention will also be summarized using empirically validated caregiver and child responses to the PKEQ questionnaire |
| Clinical outcomes based off of response to the BRIEF-2 study questionnaire | 6 weeks from trial entry | Clinical outcomes of the intervention will also be summarized using empirically validated caregiver and child responses to the BRIEF-2 questionnaire |
| Clinical outcomes based off of response to the Conners 3 study questionnaire | 6 weeks from trial entry | Clinical outcomes of the intervention will also be summarized using empirically validated caregiver and child responses to the Conners 3 questionnaire |
| Clinical outcomes based off of response to the SMALSI-2 study questionnaire | 6 weeks from trial entry | Clinical outcomes of the intervention will also be summarized using empirically validated caregiver and child responses to the SMALSI-2 questionnaire |
| Clinical outcomes based off of response to the SPSI-R study questionnaire | 6 weeks from trial entry | Clinical outcomes of the intervention will also be summarized using empirically validated caregiver and child responses to the SPSI-R questionnaire |
Countries
United States
Outcome results
None listed